Image-guided drug delivery to the brain using nanotechnology

Area of Science:

• Neuropharmaceutics
• Nanotechnology
• Medical Imaging

Background:

• Targeting the blood-brain barrier (BBB) is a major challenge in treating central nervous system (CNS) diseases.
• Nanotechnology and advanced imaging techniques are crucial for CNS disease diagnosis and treatment (theranostics).

Purpose of the Study:

• To review recent advances in nanotechnology-based theranostics for CNS diseases targeting the BBB.
• To discuss current challenges and propose future hypotheses in this field.

Main Methods:

• Review of current literature on nanotechnology, theranostics, and BBB targeting.
• Discussion of various imaging modalities including MRI, PET, SPECT, and optical imaging.
• Analysis of formulation strategies and challenges.

Main Results:

• Nanotechnology combined with imaging offers promising theranostic solutions for CNS diseases.
• Significant progress has been made in developing targeted delivery systems across the BBB.
• Various imaging techniques aid in diagnosis and monitoring treatment efficacy.

Conclusions:

• Theranostics utilizing nanotechnology and advanced imaging represent a significant advancement in neuropharmaceutics.
• Overcoming BBB challenges is key to successful CNS disease treatment.
• Further research into formulations and hypotheses is needed to optimize theranostic applications.